Cutaneous viral infections in HIV-infected individuals
Tóm tắt
Từ khóa
Tài liệu tham khảo
Safran, 1991, Clinical and serological features of herpes simplex virus infection in patients with AIDS, AIDS, 5, 1107, 10.1097/00002030-199109000-00008
Corey, 1986, Infections with herpes simplex viruses (part II), N Engl J Med, 314, 749, 10.1056/NEJM198603203141205
Siegal, 1981, Severe acquired immunodeficiency in male homosexuals manifested by chronic perianal ulcerative herpes simplex lesions, N Engl J Med, 305, 1439, 10.1056/NEJM198112103052403
Norris, 1988, Severe progressive herpetic whitlow caused by an acyclovir-resistant virus in a patient with AIDS (letter), J Infect Dis, 157, 209, 10.1093/infdis/157.1.209
Zimmerli, 1988, Disseminated herpes simplex type 2 in systemic candida infection in a patient with previous asymptomatic human immunodeficiency virus infection (letter), J Infect Dis, 157, 597, 10.1093/infdis/157.3.597
Marks, 1989, Mucocutaneous dissemination of acyclovir-resistant herpes simplex virus in a patient with AIDS, Rev Infect Dis, 11, 474, 10.1093/clinids/11.3.474
Simonson, 1988, Human immunodeficiency virus infection among men with sexually transmitted diseases, N Engl J Med, 319, 274, 10.1056/NEJM198808043190504
Stamm, 1988, The association between genital ulcerative disease and acquisition of HIV infection in homosexual men, JAMA, 260, 1429, 10.1001/jama.260.10.1429
Shacker, 1998, Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1 infected men, JAMA, 280, 61, 10.1001/jama.280.1.61
Mole, 1997, The impact of active herpes simplex virus infection on human immunodeficiency virus load, J Infect Dis, 176, 766, 10.1086/517297
Jura, 1989, Varicella zoster virus infections in children infected with human immunodeficiency virus, Pediatr Infect Dis J, 8, 856, 10.1097/00006454-198909000-00003
Janier, 1988, Chronic varicella zoster infection in acquired immunodeficiency syndrome (letter), J Am Acad Dermatol, 18, 584, 10.1016/S0190-9622(88)80295-0
Cohen, 1988, Disseminated herpes zoster in patients with immunodeficiency virus infection, Am J Med, 84, 1076, 10.1016/0002-9343(88)90315-4
Jacobson, 1990, Acyclovir-resistant varicella zoster virus infection after chronic oral acyclovir therapy in patients with the acquired immunodeficiency syndrome (AIDS), Ann Intern Med, 112, 187, 10.7326/0003-4819-112-3-187
Reichart, 1989, Oral hairy leukoplakia, J Oral Pathol Med, 18, 410, 10.1111/j.1600-0714.1989.tb01573.x
Greenspan, 1991, Risk factors for rapid progression from hairy leukoplakia to AIDS, J Acquir Immune Defic Syndr, 4, 652
Greenspan, 1985, Replication of Epstein-Barr virus within epithelial cells of oral “hairy” leukoplakia and AIDS-associated lesion, N Engl J Med, 313, 1564, 10.1056/NEJM198512193132502
Gaglioti, 1989, Oral hairy leukoplakia, Fifth International Conference on AIDS. Montreal, June 4–9, 473
Klatt, 1988, Cytomegalovirus infection in the acquired immunodeficiency syndrome, Arch Pathol Lab Med, 112, 540
Minars, 1977, Fatal cytomegalic inclusion disease, Arch Dermatol, 113, 1569, 10.1001/archderm.113.11.1569
Muehler-Stamou, 1974, Epidermolysis in a case of severe cytomegalovirus infection, BMJ, 3, 609, 10.1136/bmj.3.5931.609
Chang, 1994, Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi’s sarcoma, Science, 266, 1865, 10.1126/science.7997879
Rady, 1995, Herpesvirus-like DNA sequences in Kaposi’s and non-Kaposi’s sarcoma skin lesions of transplant patients, Lancet, 345, 1339, 10.1016/S0140-6736(95)92538-4
Evans, 1998, Advances in antiviral therapy in dermatology, Dermatol Therapy, 16, 409
Wagstaff, 1994, Acyclovir, a reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy, Drugs, 47, 153, 10.2165/00003495-199447010-00009
Goldberg, 1993, The acyclovir study group. Long-term suppression of recurrent genital herpes with acyclovir, Arch Dermatol, 129, 582, 10.1001/archderm.129.5.582
Perrin, 1996, Combination therapy in primary HIV infection, Antiviral Res, 29, 87, 10.1016/0166-3542(95)00925-6
Wald, 1996, Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir, Ann Intern Med, 124, 8, 10.7326/0003-4819-124-1_Part_1-199601010-00002
Huff JC, Drucker JL, Clemmer A, et al. Effect of oral acyclovir on pain resolution in herpes zoster. A reanalysis. J Med Virol 1993.
Saltzman, 1994, Safety of famciclovir in patients with herpes zoster and genital herpes, Antimicrob Agents Chemother, 38, 2454, 10.1128/AAC.38.10.2454
Heng, 1994, Co-infection and synergy of human immunodeficiency virus-1 and herpes simplex virus 1, Lancet, 343, 255, 10.1016/S0140-6736(94)91110-X
Stanley, 1996, Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1, N Engl J Med, 334, 1222, 10.1056/NEJM199605093341903
Schacker T, Lu H, Zeh J, et al. HSV suppression is associated with a significant decrease in plasma levels of HIV. Fifth Conference on Retroviruses and Opportunistic Infections, Alexandria, VA, 1998. Abstract 260.
Weller, 1993, Pharmacokinetics of the acyclovir prodrug valaciclovir after escalating single multiple-dose administration to normal volunteers, Clin Pharmacol Ther, 54, 595, 10.1038/clpt.1993.196
Lawrence A, Bell A. Valaciclovir for prevention of recurrent herpes virus infection in HIV-infected individuals—a double blind control trial. Eighth European Congress of Clinical Microbiology and Infectious Diseases. Abstract, May 25–28, 1997, Lausanne, Switzerland.
Jackson, 1997, The effect of treating herpes zoster with oral acyclovir in preventing postherpetic neuralgia, Arch Intern Med, 157, 909, 10.1001/archinte.157.8.909
Herne, 1996, Advances in antiviral therapy, Curr Opin Dermatol, 3, 195
Thandi, 1997, Newer aspects of herpesvirus infections, 42
Tyring, 1995, Famciclovir for the treatment of acute herpes zoster, Ann Intern Med, 123, 89, 10.7326/0003-4819-123-2-199507150-00002
Schacker, 1998, Famciclovir for the suppression of symptomatic and asymptomatic herpes simplex virus reactivation in HIV-infected persons, Ann Intern Med, 128, 21, 10.7326/0003-4819-128-1-199801010-00004
Reyes M, Graber J, Reeves W. Acyclovir resistant HSV: Preliminary results from a national surveillance system. International Conference on Emerging Infectious Diseases, Abstract, March 8–11, 1998, Atlanta, GA.
Burnside A, Preston A, Crann R, et al., and the Famciclovir Genital HSV in HIV Study Group. Famciclovir for suppression of recurrent genital herpes in HIV-infected patients. IDSA, Abstract, November 13, 1998, Denver, Colorado.
Birch, 1988, Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome, J Infect Dis, 162, 731, 10.1093/infdis/162.3.731
Chatis, 1989, Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome, N Engl J Med, 320, 297, 10.1056/NEJM198902023200507
Youle, 1988, Acyclovir-resistant herpes in AIDS patients treated with Foscarnet, Lancet, 2, 341, 10.1016/S0140-6736(88)92402-6
Erlich, 1989, Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome, N Engl J Med, 320, 293, 10.1056/NEJM198902023200506
Safrin, 1990, Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients, J Infect Dis, 161, 1078, 10.1093/infdis/161.6.1078
Lalezari, 1997, A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS, J Infect Dis, 176, 892, 10.1086/516542
Kessler, 1988, Regression of oral hairy leukoplakia during treatment with azidothymidine, Ann Intern Med, 148, 2496, 10.1001/archinte.148.11.2496
Schofer, 1987, Treatment of oral hairy leukoplakia in AIDS patients with vitamin A acid (topically) or acyclovir (systemically) (letter), Dermatologica, 174, 150, 10.1159/000249008
1986, Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl) guanine in patients with AIDS and other immunodeficiencies, N Engl J Med, 314, 801, 10.1056/NEJM198603273141301
Zabawski, 1998, Topical and intralesional cidofovir, J Am Acad Dermatol, 39, 741, 10.1016/S0190-9622(98)70046-5
De Clercq, 1996, Therapeutic potential of cidofovir (HPMPC, Vistide) for the treatment of DNA virus (ie, herpes-, papova-, pox- and adenovirus) infections, Verh K Acad Geneeskd Belg, 58, 19
Palefsky, 1995, Human papillomavirus-associated malignancies in HIV-positive men and women, Curr Opin Oncol, 7, 437, 10.1097/00001622-199509000-00009
Klein, 1994, Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection, J Infect Dis, 170, 1404, 10.1093/infdis/170.6.1404
Palefsky, 1994, Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men, J Acquir Immune Defic Syndr, 7, 599
Williams, 1994, Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women, Obstet Gynecol, 83, 205
Spinillo, 1992, Prevalence, diagnosis and treatment of lower genital neoplasia in women with human immunodeficiency virus infection, Eur J Obstet Gynecol Reprod Biol, 43, 235, 10.1016/0028-2243(92)90179-3
Sun, 1995, Human papillomavirus infection in human immunodeficiency virus-seropositive women, Obstet Gynecol, 85, 680, 10.1016/0029-7844(95)00025-M
Seck, 1994, Cervical intraepithelial neoplasia and human papillomavirus infection among Senegalese women seropositive for HIV-1 or HIV-2 or seronegative for HIV, Int J STD AIDS, 5, 189, 10.1177/095646249400500307
Petry, 1996, Human papillomavirus is associated with the frequent detection of warty and basaloid high-grade neoplasia of the vulva and cervical neoplasia among immunocompromised women, Gynecol Oncol, 60, 30, 10.1006/gyno.1996.0007
Chirgwin, 1995, Incidence of venereal warts in human immunodeficiency virus-infected and uninfected women, J Infect Dis, 172, 235, 10.1093/infdis/172.1.235
Tweddel, 1994, The correlation between HIV seropositivity, cervical dysplasia, and HPV subtypes 6/11, 16/18, 31/33/35, Gynecol Oncol, 52, 161, 10.1006/gyno.1994.1024
Breese, 1995, Anal human papillomavirus infection among homosexual and bisexual men, Sex Transm Dis, 22, 7, 10.1097/00007435-199501000-00002
Bernard, 1992, Viral co-infections in human papillomavirus-associated anogenital lesions according to the serostatus for the human immunodeficiency virus, Int J Cancer, 52, 731, 10.1002/ijc.2910520511
Garzetti, 1995, Cervical dysplasia in HIV-seropositive women, Gynecol Obstet Invest, 40, 52, 10.1159/000292302
Vernon, 1994, A longitudinal study of human papillomavirus DNA detection in human immunodeficiency virus type 1-seropositive and -seronegative women, J Infect Dis, 169, 1108, 10.1093/infdis/169.5.1108
Stratton, 1994, Cervical neoplasia in the patient with HIV infection, Curr Opin Obstet Gynecol, 6, 86, 10.1097/00001703-199402000-00014
Baker, 1994, Management of the female HIV-infected patient, AIDS Res Hum Retroviruses, 10, 935, 10.1089/aid.1994.10.935
Ho, 1994, Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression, Int J Cancer, 56, 788, 10.1002/ijc.2910560605
Critchlow, 1995, Prospective study of high-grade anal squamous intraepithelial neoplasia in a cohort of homosexual men, AIDS, 9, 1255, 10.1097/00002030-199511000-00007
Bryan, 1998, High-grade dysplasia in genital warts from patients infected with the human immunodeficiency virus, J Med Virol, 54, 69, 10.1002/(SICI)1096-9071(199801)54:1<69::AID-JMV10>3.0.CO;2-Z
Del Mistro, 1994, Human papillomavirus infections of the genital region in human immunodeficiency virus seropositive women, Eur J Gynaecol Oncol, 15, 50
Von Krogh, 1995, Anal and penile condylomas in HIV-negative and HIV-positive men, Acta Derm Venereol, 75, 470, 10.2340/0001555575470474
Johnson, 1992, High frequency of latent and clinical human papillomavirus cervical infections in immunocompromised human immunodeficiency virus-infected women, Obstet Gynecol, 79, 321, 10.1097/00006250-199203000-00001
Wright, 1994, Cervical intraepithelial neoplasia in women infected with human immunodeficiency virus, Obstet Gynecol, 84, 591
Arany, 1998, Systemic immunosuppression by HIV infection influences HPV transcription and thus local immune responses in condyloma acuminatum, Int J STD AIDS, 9, 268, 10.1258/0956462981922197
Spinillo, 1993, Langerhans’ cell counts and cervical intraepithelial neoplasia in women with human immunodeficiency virus infection, Gynecol Oncol, 48, 210, 10.1006/gyno.1993.1035
Arany, 1996, Immunodeficiency in condylomas is associated with HPV expression (abstract), J Invest Dermatol, 106, 913
Arany, 1998, Tissue-specific HPV expression and downregulation of local immune response in condyloma from HIV-seropositive individuals, Sex Transm Inf, 74, 349, 10.1136/sti.74.5.349
Vernon, 1993, The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription, Virus Res, 27, 133, 10.1016/0168-1702(93)90077-Z
Tornosello, 1993, Human immunodeficiency virus type-1 tat gene enhances human papillomavirus early gene expression, Intervirology, 36, 57, 10.1159/000150322
Peterson, 1995, Quercetin and kaempherol, Genitourin Med, 71, 92
Ziegler, 1998, Generation of infectious retrovirus aerosol through medical laser irradiation, Lasers Surg Med, 22, 37, 10.1002/(SICI)1096-9101(1998)22:1<37::AID-LSM9>3.0.CO;2-Y
Sawchuk, 1989, Infectious papillomavirus in the vapor of warts treated with carbon dioxide laser or electrocoagulation, J Am Acad Dermatol, 21, 41, 10.1016/S0190-9622(89)70146-8
Rockley, 1995, Interferons alpha, beta, and gamma therapy of anogenital human papillomavirus infections, Pharmacol Ther, 65, 265, 10.1016/0163-7258(94)00063-9
Semprini, 1994, Treatment with interferon for genital HPV in HIV-positive and HIV-negative women, Eur J Obstet Gynecol Reprod Biol, 53, 135, 10.1016/0028-2243(94)90221-6
Tyring, 1998, A molecular study of condylomata acuminata clearance during treatment with imiquimod, J Infect Dis, 178, 551, 10.1086/517472
Edwards, 1998, Self-administered topical 5% imiquimod cream for external anogenital warts, Arch Dermatol, 134, 25, 10.1001/archderm.134.1.25
Conant, 2000, Immunomodulatory therapy in the management of viral infections in patients with HIV infection, J Am Acad Dermatol, 43, S27, 10.1067/mjd.2000.107810
Lalezari JP, Stagg RJ, Jaffe HS, et al. A preclinical and clinical overview of the nucleotide-based antiviral agent cidofovir (HPMPC). In: Mills J, Corey L, editors. Antiviral chemotherapy. New York: Plenum Publishing, 1996.
Tyring SK, Douglas J, Schacker T, et al. A phase II study of Cidofovir topical gel for refractory condyloma acuminatum in patients with HIV infection. 55th Annual Meeting of the American Academy of Dermatology, March 21–26, 1997, San Francisco, California. Abstract p. 296.
Berger, 1991, Bacterial, viral, fungal and parasitic infections in HIV disease and AIDS, Dermatol Clin, 3, 465, 10.1016/S0733-8635(18)30396-6
Meadows, 1997, Resolution of recalcitrant molluscum contagiosum virus lesions in human immunodeficiency virus-infected patients treated with cidofovir, Arch Dermatol, 133, 987, 10.1001/archderm.133.8.987
Torok, 1992, Parvovirus and human disease, Adv Intern Med, 37, 431